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we achieved what we set out to do, have the consequences of treatment been worth the outcome and is this economically viable. The collection of relevant data and its intelligent use is critical. Data that allows measurement of the impact of side effects of treatments both short and long term along a patients entire continuum of care, their global quality of life, the economic impact across the board and whether outcomes have influenced practice, and policy are all important. Knowing how cancer and treatment affect individuals is critical in trying to determine whether any intervention is effective, tolerable and acceptable. The Cancer Outcomes Measurement Working Group (COMWG) has provided a more inclusive method of global assessment (3) . This Group describes current best practices and recommendations for assessing the following three outcomes across the continuum of care: health-related quality of life; economic burden; and patient satisfaction; The Radiation Oncology community has developed a scoring system for recording Common Toxicity Criteria both for acute and long term symptoms and collection of quality of life data in radiation oncology clinical trials is becoming routine (4) . A number of radiation oncology and medical oncology trials groups have consumers involved in the development of trials and on the trial management committees along with experts in quality of life. For Interventional Oncology, having access to alarge and relevant data repository that allows for such global evaluation iscritical. Expanding data collection beyond the RECIST criteria to encompass themore global measures discussed above needs to become routine if interventional oncology treatments are to become incorporated into mainstream care, funded andvalued. Purpose/Objective: MRI has a high sensitivity for tumor detection and a good correlation with histopathology findings. The precision of preoperative target volume delineation on newly developed 3D supine CE-MRI was compared to preoperative delineation on CE-CT in patients treated with breast-conserving therapy. Materials and Methods: We tested a newly developed 3D high resolution MRI protocol for target volume delineation in RT supine position in 14 cT1-2N0 patients. Gross tumor volumes (GTVs) were delineated by 4 experienced breast radiation oncologists, following written delineation instructions, on preoperative contrast-enhanced (CE) CT (1x1 mm 2 in plane resolution, 3 mm slice thickness) and 3D CE-MRI (voxel size 1.2x1.2x1.2 mm 3 ). To assess whether differences in GTV delineation were also clinically relevant, clinical target volumes (CTVs) were created by addition of a 1.5 cm margin around the tumor volume excluding the skin and chest wall. Interobserver variability (IOV) was assessed by calculating the conformity index (CI) and the center of mass distance (dCOM) for both the GTV and CTV in each patient. Tumor characteristics on CE-CT and CE-MRI were assessed and scored by an experienced breast radiologist. Results: In figure 1, target volume delineations of the 4 observers are shown on both preoperative CE-CT and CE-MRI in the same patient. The median CI of the GTV was higher on CE-MRI compared to CE-CT (Table 1) . After expansion to the CTV, this difference in CI was no longer statistically significant. However, an incorrect GTV was delineated on CE-CT in 2/14 patients (14%) by multiple observers (1/4 and 3/4 observers in each misdelineated patient). This resulted in high ranges of the CI on CE-CT. Tumor shapes were rated as more irregular and spiculated on CE-MRI. This did not result in a decreased CI on CE-MRI. A uniform volume expansion of GTV to CTV resulted in larger volumes on CE-MRI compared to CE-CT. No difference in median dCOM was observed between both image modalities.
CI Conformity Index, GTV gross tumor volume, CTV clinical target volume, dCOM center of mass distance. Mean volume and dCOM were calculated per patient, median values were calculated over the included patient population. Conclusions: Preoperative target volume delineation showed a higher precision on 3D CE-MRI compared to CE-CT. A more irregular and spiculated tumor was visualized on CE-MRI without a decrease of interobserver agreement. Future studies will focus on using preoperative CE-MRI guided delineation in preoperative, as well as additional information in postoperative, whole or accelerated partial breast irradiation. 
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